Low false-positive lymph nodes for 18F-fibroblast activation protein inhibitors PET/computed tomography in preoperative staging of patients with nonsmall cell lung cancer.

MLA

Mu, Xingyu, et al. “Low False-Positive Lymph Nodes for 18F-Fibroblast Activation Protein Inhibitors PET/Computed Tomography in Preoperative Staging of Patients with Nonsmall Cell Lung Cancer.” Nuclear Medicine Communications, Oct. 2024. EBSCOhost, https://doi.org/10.1097/MNM.0000000000001913.

APA

Mu, X., Lu, L., Li, J., Zhang, L., Deng, Y., & Fu, W. (2024). Low false-positive lymph nodes for 18F-fibroblast activation protein inhibitors PET/computed tomography in preoperative staging of patients with nonsmall cell lung cancer. Nuclear Medicine Communications. https://doi.org/10.1097/MNM.0000000000001913

Chicago

Mu, Xingyu, Ludeng Lu, Jingze Li, Lei Zhang, Yanyun Deng, and Wei Fu. 2024. “Low False-Positive Lymph Nodes for 18F-Fibroblast Activation Protein Inhibitors PET/Computed Tomography in Preoperative Staging of Patients with Nonsmall Cell Lung Cancer.” Nuclear Medicine Communications, October. doi:10.1097/MNM.0000000000001913.